TABLE 4 

Activities derived from the receptor screen at various sites expressed as % displacement at 10 μM and estimated Ki values relative to DAT affinity

Sites at which at least one of the compounds showed greater than 50% inhibition of radioligand binding at 10 μM are shown.

Target% InhibitionRelative to DATa
LX19 (β)LX20 (α)LX19 (β)LX20 (α)
Adenosine A2A57Inactive60Inactive
Adrenergic α2A9499<7.3<0.56
DA D1R7680221.8
DA D2LRInactive63Inactive2.6
DA D3R609732<0.56
Histamine H2Inactive69Inactive0.16
Muscarinic M2859910<0.53
Opioid δ5876361.5
Opioid κ8477121.6
Opioid μInactive52Inactive5.3
5-HT1A6510242<0.74
5-HT2A9698<5.1<0.45
Na Channel, Site 29498<17<1.4
  • a See Materials and Methods for details regarding derivation of affinities relative to DAT. Briefly, for sites at which compounds produced between 10 and 90% displacement, an IC50 value was derived by linear interpolation assuming a displacement curve spanning a 100-fold domain of concentrations. For sites at which the displacement was >90%, IC50 values were estimated to be <1 μM. The compound was considered inactive at sites for which the displacement by 10 μM was <10%. Ki values were derived from estimated IC50 values and the Cheng-Prusoff equation using Kd values of radioligands provided by the vendor. This method follows a practice used by Kosterlitz et al. (1973) to estimate potencies of opioids for inhibition of guinea pig ileum contractions at single concentrations. The Ki values are presented in the table as ratio Ki values (LX compound/DAT), with values for the DAT determined in the present study (Table 3).